Cholinergic neuroplasticity in asthma driven by TrkB signaling.

Autor: Dragunas G; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pharmacology, University of São Paulo, São Paulo, Brazil., Woest ME; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Nijboer S; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bos ST; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Asselt J; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot AP; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Vohlídalová E; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Vermeulen CJ; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pulmonary Diseases, UMCG, Groningen, the Netherlands., Ditz B; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pulmonary Diseases, UMCG, Groningen, the Netherlands., Vonk JM; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Epidemiology, UMCG, Groningen, the Netherlands., Koppelman GH; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pediatric Pulmonology and Pediatric Allergology, University Medical Center Groningen, University of Groningen, Beatrix Children's Hospital, Groningen, the Netherlands., van den Berge M; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pulmonary Diseases, UMCG, Groningen, the Netherlands., Ten Hacken NHT; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pulmonary Diseases, UMCG, Groningen, the Netherlands., Timens W; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pathology, UMCG, Groningen, the Netherlands., Munhoz CD; Department of Pharmacology, University of São Paulo, São Paulo, Brazil., Prakash YS; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA., Gosens R; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kistemaker LEM; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2020 Jun; Vol. 34 (6), pp. 7703-7717. Date of Electronic Publication: 2020 Apr 11.

Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders.

Autor: Petroková H; Laboratory of Ligand Engineering, Institute of Biotechnology, Czech Academy of Sciences, v.v.i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic., Mašek J; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Kuchař M; Laboratory of Ligand Engineering, Institute of Biotechnology, Czech Academy of Sciences, v.v.i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic., Vítečková Wünschová A; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Štikarová J; Department of Biochemistry, Institute of Hematology and Blood Transfusion, U nemocnice 2094/1, 128 20 Praha 2, Czech Republic., Bartheldyová E; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Kulich P; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Hubatka F; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Kotouček J; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Knotigová PT; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Vohlídalová E; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Héžová R; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Mašková E; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic., Macaulay S; Malvern Instruments Ltd., Enigma Business Park, Grove Lane, Malvern WR14 1XZ, UK., Dyr JE; Department of Biochemistry, Institute of Hematology and Blood Transfusion, U nemocnice 2094/1, 128 20 Praha 2, Czech Republic., Raška M; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic.; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic., Mikulík R; The International Clinical Research Center ICRC and Neurology Department of St. Anne's University Hospital in Brno, Pekařská 53, 656 91 Brno, Czech Republic., Malý P; Laboratory of Ligand Engineering, Institute of Biotechnology, Czech Academy of Sciences, v.v.i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic., Turánek J; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, v.v.i., Hudcova 70, 621 00 Brno, Czech Republic.

Publikováno v: Pharmaceutics [Pharmaceutics] 2019 Dec 02; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 02.

Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D.

Autor: Dubashynskaya, Natallia V.¹ (AUTHOR), Petrova, Valentina A.¹ (AUTHOR), Skorik, Yury A.¹ (AUTHOR) yury_skorik@mail.ru

Publikováno v: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5359. 32p.

Polymers used in pharmaceutical industry for oral delivery: insight to synthesis, structure–activity relationship, and recent applications.

Autor: Mori, Dhaval, Dudhat, Kiran, Soniwala, Moinuddin, Parmar, Ramesh, Suthar, Devi, Jayani, Rutvi, Shah, Sunny, Borkhataria, Chetan, Patel, Kalpesh, Dudhrejiya, Ashwin

Publikováno v: Polymer Bulletin; Dec2024, Vol. 81 Issue 18, p16373-16413, 41p

Formulation and Characterization of Mupirocin Nanomicelles in Insulin-Based Gel for Dermatological Application.

Autor: Zubairi, Maysaa B.¹ phmaysaaalbasri@gmail.com, Abd, Abdulkareem H.², Al-lami, Mohammed S.³

Publikováno v: Journal of Pharmacy & Bioallied Sciences. 2023 Supplement, Vol. 15, pS1178-S1181. 4p.